For the first time a vaccine will be available to help seniors fight RSV -- respiratory syncytial virus -- for the fall respiratory season, though potentially in a limited amount for the start.
The vaccine was developed by GSK. Dessi Loukov, Scientific Lead – Vaccines, GSK, joins Patricia Boal to talk through RSV and its health risks and how the vaccine can make a difference in confronting those.
OAW: Canada approves first RSV vaccine for seniors age 60+ ahead of respiratory virus season - iheartradio.ca
Read More
No comments:
Post a Comment